COE Drug Checking - JHF

June 3, 2026

Participants will recognize how drug checking services reduce overdose risk and explore the evolving risks of an unpredictable drug supply. They will also learn how to integrate drug checking education into harm reduction strategies, connect clients to available resources, and collaborate with partners to support safer use and informed decision-making.

Agenda:

  1. Introduction
  2. Current Drug Supply Landscape
    1. Lack of consumer protections for people who use drugs
    2. Volatility and unpredictability of the illicit drug supply
    3. Lag between changes in supply and awareness of harms
    4. Lived experience example illustrating delayed recognition of xylazine-related harm
  3. Clinical and public health consequences of unknown substances
    1. Relationship between drug supply changes and:
      1. Overdose risk
      2. Wound development
      3. Delayed care-seeking
      4. Drug checking as a harm reduction response
  4. Role of Drug Checking in Harm Reduction
    1. Definition of drug checking
    2. How drug checking:
      1. Reduces overdose risk
      2. Supports informed decision-making
      3. Leads to behavior change
      4. Informs local interventions and outreach strategies
  5. Types of Drug Checking Services
    1. Distributable tools
    2. Immunoassay test strips
    3. Reagent test kits
    4. Point-of-service drug checking
    5. Laboratory-based analytical testing
    6. LC/GC-MS, QTOF, FTIR
    7. Tradeoffs: cost, time, complexity
    8. Clarifying what drug checking is not
    9. Urine toxicology screens
  6. Nuances and Best Practices
    1. High prevalence of fentanyl in Pennsylvania
    2. Appropriate deployment of fentanyl test strips for stimulant users
    3. False positives and cross-reactivity
    4. Counseling points:
    5. “Test shot” concept
    6. Start low, go slow
    7. Following package instructions
  7. Legal Status of Drug Checking in Pennsylvania
    1. Overview of Act 111 (2022)
    2. What is legal to possess and distribute
    3. Implications for COE operations
  8. Access to Drug Checking Services
    1. Community-based access points
    2. Mail-based drug checking programs
    3. Anonymous and voluntary participation
    4. Rapid identification of local drug supply changes
  9. Integrating Drug Checking into COE Practice
  10. How COEs can incorporate drug checking education
  11. Linking clients to drug checking resources
  12. Partnering with harm reduction organizations
  13. Using drug checking data to inform outreach and care planning
  14. Key Takeaways
  15. Skill Practice
  16. Discussion

Target Audience

  • Nurse
  • Physician
  • Social Worker

Learning Objectives

• Recognize how drug checking services reduce overdose risk among high-risk populations.
• Understand available mail-in drug checking resources and their relevance for COE outreach.
• Integrate drug checking education into harm reduction strategies with COE clients.
• Collaborate with external partners to connect clients to safe drug checking options.

 

 

Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 1.25 ASWB
  • 1.25 Attendance
Course opens: 
06/03/2026
Course expires: 
06/20/2026
Event starts: 
06/03/2026 - 12:00pm EDT
Event ends: 
06/03/2026 - 1:30pm EDT

Participants will recognize how drug checking services reduce overdose risk and explore the evolving risks of an unpredictable drug supply. They will also learn how to integrate drug checking education into harm reduction strategies, connect clients to available resources, and collaborate with partners to support safer use and informed decision-making.

Agenda:

  1. Introduction
  2. Current Drug Supply Landscape
    1. Lack of consumer protections for people who use drugs
    2. Volatility and unpredictability of the illicit drug supply
    3. Lag between changes in supply and awareness of harms
    4. Lived experience example illustrating delayed recognition of xylazine-related harm
  3. Clinical and public health consequences of unknown substances
    1. Relationship between drug supply changes and:
      1. Overdose risk
      2. Wound development
      3. Delayed care-seeking
      4. Drug checking as a harm reduction response
  4. Role of Drug Checking in Harm Reduction
    1. Definition of drug checking
    2. How drug checking:
      1. Reduces overdose risk
      2. Supports informed decision-making
      3. Leads to behavior change
      4. Informs local interventions and outreach strategies
  5. Types of Drug Checking Services
    1. Distributable tools
    2. Immunoassay test strips
    3. Reagent test kits
    4. Point-of-service drug checking
    5. Laboratory-based analytical testing
    6. LC/GC-MS, QTOF, FTIR
    7. Tradeoffs: cost, time, complexity
    8. Clarifying what drug checking is not
    9. Urine toxicology screens
  6. Nuances and Best Practices
    1. High prevalence of fentanyl in Pennsylvania
    2. Appropriate deployment of fentanyl test strips for stimulant users
    3. False positives and cross-reactivity
    4. Counseling points:
    5. “Test shot” concept
    6. Start low, go slow
    7. Following package instructions
  7. Legal Status of Drug Checking in Pennsylvania
    1. Overview of Act 111 (2022)
    2. What is legal to possess and distribute
    3. Implications for COE operations
  8. Access to Drug Checking Services
    1. Community-based access points
    2. Mail-based drug checking programs
    3. Anonymous and voluntary participation
    4. Rapid identification of local drug supply changes
  9. Integrating Drug Checking into COE Practice
  10. How COEs can incorporate drug checking education
  11. Linking clients to drug checking resources
  12. Partnering with harm reduction organizations
  13. Using drug checking data to inform outreach and care planning
  14. Key Takeaways
  15. Skill Practice
  16. Discussion

 

Zoom Meeting
Pittsburgh, PA
United States

Raagini Jawa, MD, MPH, FASAM

Austen Markus, MPH

 

In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and The Jewish Healthcare Foundation. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
As a Jointly Accredited Organization, University of Pittsburgh is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. University of Pittsburgh maintains responsibility for this course. Social workers completing this course receive 1.25 continuing education credits.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.25 contact hours.

Social Work (ASWB)
The maximum number of hours awarded for this Continuing Social Work Education activity is 1.25 contact hours.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 1.25 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 1.25 ASWB
  • 1.25 Attendance
Please login or register to take this course.